Insights from 2023 ASH Annual Meeting

 

Insights from 2023 ASH Annual Meeting
B

ASH 2023 Insights: "Prognostic Utility of MRD After Curative Intent Induction Therapy for DLBCL - A Prospective Real-World ctDNA Study"

By Insights from 2023 ASH Annual Meeting FEATURING Brian Sworder
By Insights from 2023 ASH Annual Meeting FEATURING Brian Sworder
135 views
December 18, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
Lymphoma
06:43

ASH 2023 Summary: "The Best of MCL - Highlights & Key Takeaways"

Insights from 2023 ASH Annual Meeting

V. Yazbeck

173 views
11:40

ASH 2023 Insights: "The European MCL Network R2 Elderly Trial - R2 v…

Insights from 2023 ASH Annual Meeting

V. Ribrag

41 views
08:29

ASH 2023 Insights: "CAR T-Cell Therapy in Aggressive Lymphomas - Ide…

Insights from 2023 ASH Annual Meeting

A. Sureda

74 views
05:12

ASH 2023 Insights: "Results From ELM-2, a Ph 2 Study of Odronextamab…

Insights from 2023 ASH Annual Meeting

J. C. Villasboas

60 views
08:30

ASH 2023 Insights: "PD-1 Blockade Before AutoSCT in R/R Classic Hodg…

Insights from 2023 ASH Annual Meeting

S. Desai

92 views
11:11

ASH 2023 Insights: "Ibrutinib and Venetoclax in Symptomatic, Treatme…

Insights from 2023 ASH Annual Meeting

J. Castillo

119 views
09:27

ASH 2023 Insights: "Ph2 EpiRCHOP Study - Tazemetostat With R-CHOP in…

Insights from 2023 ASH Annual Meeting

C. Sarkozy

106 views
09:10

ASH 2023 Insights: "Acalabrutinib Added to Lenalidomide & Rituximab …

Insights from 2023 ASH Annual Meeting

P. Strati

71 views
06:00

ASH 2023 Insights: "Effectiveness of CIT and Novel Therapies in 2L+ …

Insights from 2023 ASH Annual Meeting

L. Nastoupil

107 views
09:05

ASH 2023 Insights: "Time-Limited Exposure to a ROR1-Targeting Bispec…

Insights from 2023 ASH Annual Meeting

P. Jasani

38 views
06:09

CLL/SLL: Outcomes of Pts With Richter's Transformation Without Prior…

Insights from 2023 ASH Annual Meeting

A. Kittai

360 views
05:45

ASH 2023 Insights: "Anti-CD19 CAR T-Cell Therapy for Richter's Trans…

Insights from 2023 ASH Annual Meeting

A. Kittai

50 views
13:38

ASH 2023 Insights: "S1826 Trial - Nivo-AVD Compared to Brentuximab V…

Insights from 2023 ASH Annual Meeting

S. Castellino

35 views
02:27

ASH 2023 Insights: "Efficacy of Mosunetuzumab Monotherapy in Patient…

Insights from 2023 ASH Annual Meeting

C. Cheah

69 views
02:26

ASH 2023 Insights: "Obinutuzumab, Lenalidomide, and Venetoclax in Pa…

Insights from 2023 ASH Annual Meeting

C. Cheah

48 views
10:19

ASH 2023 Insights: "Final Analysis of the ELM-2 Study - Odronextamab…

Insights from 2023 ASH Annual Meeting

S. Ayyappan

129 views
10:57

ASH 2023 Insights: "Mosunetuzumab + Polatuzumab Vedotin in Pts With …

Insights from 2023 ASH Annual Meeting

E. Budde

132 views
13:46

ASH 2023 Insights: "Smart Stop Trial - Lenalidomide, Tafasitamab, Ri…

Insights from 2023 ASH Annual Meeting

J. Westin

187 views
30:24

ASH 2023 Insights: "Treatment of Older Patients With HL in the Moder…

Insights from 2023 ASH Annual Meeting

A. Evens

153 views
10:58

ASH 2023 Insights: "ViPOR Trial - Multi-Targeted Therapy With Veneto…

Insights from 2023 ASH Annual Meeting

C. Melani

60 views
11:05

ASH 2023 Insights: "Alliance A051301/BMT-CTN 1201 Study - Ibrutinib …

Insights from 2023 ASH Annual Meeting

C. Andreadis

41 views
06:30

ASH 2023 Insights: "Pirtobrutinib in R/R FL - Results From the Ph1/2…

Insights from 2023 ASH Annual Meeting

N. Shah

68 views
11:11

ASH 2023 Insights: "Prognostic Utility of MRD After Curative Intent …

Insights from 2023 ASH Annual Meeting

B. Sworder

135 views
08:59

ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in Older …

Insights from 2023 ASH Annual Meeting

S. Rutherford

208 views
11:43

ASH 2023 Insights: "Selection of Bispecific Antibody Therapies or CA…

Insights from 2023 ASH Annual Meeting

M. Kamdar

182 views
16:09

ASH 2023 Insights: "Addition of Inotuzumab Ozogamicin to the Conditi…

Insights from 2023 ASH Annual Meeting

I. Khouri

27 views
10:21

ASH 2023 Insights: "EOT Response Assessment After 1L Tx For Aggressi…

Insights from 2023 ASH Annual Meeting

M. Roschewski

82 views
13:06

ASH 2023 Insights: "ECOG-ACRIN E4412 Study of Ipi, Nivo, and Brentux…

Insights from 2023 ASH Annual Meeting

C. Diefenbach

24 views
18:05

ASH 2023 Insights: "Optimal Management of R/R cHL - Post-Brentuximab…

Insights from 2023 ASH Annual Meeting

N. Grover

25 views
09:56

ASH 2023 Insights: "Limited Duration Loncastuximab Tesirine With Rit…

Insights from 2023 ASH Annual Meeting

J. Pablo Alderuccio

54 views
11:42

ASH 2023 Insights: "Impact of Large Cells and Ki-67% on Outcomes in …

Insights from 2023 ASH Annual Meeting

N. Epperla

84 views
04:34

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Insights from 2023 ASH Annual Meeting

P. Jain

196 views
05:10

ASH 2023 Insights: "Efficacy of Double Step-Up Dosing of AZD0486, a …

Insights from 2023 ASH Annual Meeting

S. Gaballa

93 views
05:41

ASH 2023 Insights: "Acalabrutinib With Rituximab as 1L Therapy for O…

Insights from 2023 ASH Annual Meeting

P. Jain

48 views
04:56

ASH 2023 Insights: "Immune Reconstitution and Infection Patterns Fol…

Insights from 2023 ASH Annual Meeting

M. Melody

115 views
10:28

ASH 2023 Insights: "Multicenter Study of MCL Outcomes Following 1L B…

Insights from 2023 ASH Annual Meeting

Y. Wang

60 views